We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oral COTI-2 is Effective Against Aggressive Triple Negative Human Breast Cancer

News   Apr 02, 2010

 
Oral COTI-2 is Effective Against Aggressive Triple Negative Human Breast Cancer
 
 
 

RELATED ARTICLES

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

Plant Immunity Cut to Size

News

Researchers have found a link between a class of enzymes and immune signals that is rapidly triggered upon physical damage in plants.

READ MORE

European Bioinformatics Institute Launches Protein Data Bank

News

EMBL’s European Bioinformatics Institute (EMBL-EBI) and collaborators have launched a new data resource, called Protein Data Bank in Europe Knowledge Base (PDBe-KB), which gives researchers a more comprehensive view of publicly available protein structure data.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE